These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 1820885)
1. Human pharmacokinetics and metabolism of disopyramide enantiomers. Le Corre P; Gibassier D; Sado P; Le Verge R Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():233-7. PubMed ID: 1820885 [TBL] [Abstract][Full Text] [Related]
2. Stereoselective metabolism and pharmacokinetics of disopyramide enantiomers in humans. Le Corre P; Gibassier D; Sado P; Le Verge R Drug Metab Dispos; 1988; 16(6):858-64. PubMed ID: 2907466 [TBL] [Abstract][Full Text] [Related]
3. Stereoselective pharmacokinetics of disopyramide enantiomers in man. Lima JJ; Boudoulas H; Shields BJ Drug Metab Dispos; 1985; 13(5):572-7. PubMed ID: 2865105 [TBL] [Abstract][Full Text] [Related]
4. Stereoselective disposition and metabolism of disopyramide in pediatric patients. Echizen H; Takahashi H; Nakamura H; Ochiai K; Chiba K; Koike K; Ogata H; Ishizaki T J Pharmacol Exp Ther; 1991 Dec; 259(3):953-60. PubMed ID: 1762088 [TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics, protein binding and antiarrhythmic effects of disopyramide enantiomers in arrhythmic patients. Aso R; Ohashi K; Katoh T; Ogata H Int J Clin Pharmacol Res; 2001; 21(3-4):137-46. PubMed ID: 12067143 [TBL] [Abstract][Full Text] [Related]
6. Stereoselectivity in the metabolism of disopyramide enantiomers in rat and dog. Cook CS; Karim A; Sollman P Drug Metab Dispos; 1982; 10(2):116-21. PubMed ID: 6124395 [TBL] [Abstract][Full Text] [Related]
7. Stereoselective biliary elimination of disopyramide and mono-N-desisopropyldisopyramide in humans. le Corre P; Malledant Y; Chevanne F; Sado P; le Verge R Chirality; 1992; 4(2):80-3. PubMed ID: 1616827 [TBL] [Abstract][Full Text] [Related]
8. Interspecies differences in enantioselective mono-N-dealkylation of disopyramide by human and mouse liver microsomes. Echizen H; Mochizuki K; Tani M; Ishizaki T J Pharmacol Exp Ther; 1994 Mar; 268(3):1518-25. PubMed ID: 8138963 [TBL] [Abstract][Full Text] [Related]
9. In vitro assessment of stereoselective hepatic metabolism of disopyramide in humans: comparison with in vivo data. Le Corre P; Ratanasavanh D; Chevanne F; Gibassier D; Sado P; Le Verge R; Guillouzo A Chirality; 1991; 3(5):405-11. PubMed ID: 1756095 [TBL] [Abstract][Full Text] [Related]
10. Enantioselective steady-state kinetics of unbound disopyramide and its dealkylated metabolite in man. Hasselström J; Enquist M; Hermansson J; Dahlqvist R Eur J Clin Pharmacol; 1991; 41(5):481-4. PubMed ID: 1761078 [TBL] [Abstract][Full Text] [Related]
11. Differences in the stereoselective pharmacokinetics of pazinaclone (DN-2327), a new anxiolytic, and its active metabolite after intravenous and oral single doses to dogs. Hussein Z; Mulford DJ; Bopp BA; Granneman GR Drug Metab Dispos; 1993; 21(5):805-10. PubMed ID: 7902240 [TBL] [Abstract][Full Text] [Related]
12. A potent inhibitory effect of erythromycin and other macrolide antibiotics on the mono-N-dealkylation metabolism of disopyramide with human liver microsomes. Echizen H; Kawasaki H; Chiba K; Tani M; Ishizaki T J Pharmacol Exp Ther; 1993 Mar; 264(3):1425-31. PubMed ID: 8450476 [TBL] [Abstract][Full Text] [Related]
13. Simultaneous determination of disopyramide and its mono-N-dealkylated metabolite enantiomers in human plasma and urine by enantioselective high-performance liquid chromatography. Takahashi H; Tamura A; Ogata H; Masuhara K J Chromatogr; 1990 Aug; 529(2):347-58. PubMed ID: 2229254 [TBL] [Abstract][Full Text] [Related]
14. Steady-state pharmacokinetics of propranolol enantiomers in healthy male volunteers. Paradiso-Hardy FL; Walker SE; Bowles SK Int J Clin Pharmacol Ther; 1998 Jul; 36(7):370-5. PubMed ID: 9707351 [TBL] [Abstract][Full Text] [Related]
15. Protein binding of indobufen enantiomers: pharmacokinetics of free fraction-studies after single or multiple doses of rac-indobufen. Główka FK; Caldwell J Chirality; 2002 Oct; 14(9):736-41. PubMed ID: 12237835 [TBL] [Abstract][Full Text] [Related]
16. Relationship between the therapeutic effects or side-effects and the serum disopyramide or mono-N-dealkylated disopyramide concentration after repeated oral administration of disopyramide to arrhythmic patients. Masuhara K; Ohno T; Hamaguchi K; Katoh K; Kashiwada K; Takahashi S; Tanaka Y; Someya K; Ogata H Int J Clin Pharmacol Res; 1995; 15(3):103-13. PubMed ID: 8847151 [TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacokinetics of levorotatory and racemic disopyramide, at steady state, following oral administration in patients with ventricular arrhythmias. Le Corre P; Gibassier D; Descaves C; Sado P; Daubert JC; Le Verge R J Clin Pharmacol; 1989 Dec; 29(12):1089-96. PubMed ID: 2482304 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and optimum dose of disopyramide in patients with chronic renal failure. Nagura Y; Kuno T; Yanai M; Maejima M; Okada K; Maeda H; Inoue M; Takahashi S; Hatano M Nihon Jinzo Gakkai Shi; 1991 May; 33(5):539-43. PubMed ID: 1895553 [TBL] [Abstract][Full Text] [Related]
19. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers. Fornasini G; Monti N; Brogin G; Gallina M; Eandi M; Persiani S; Bani M; Della Pepa C; Zara G; Strolin Benedetti M Chirality; 1997; 9(3):297-302. PubMed ID: 9176996 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and steady-state myocardial uptake of disopyramide in the dog. Karim A; Kook C; Novotney RL; Zagarella J; Campion J Drug Metab Dispos; 1978; 6(3):338-45. PubMed ID: 26556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]